A pragmatic randomised double-blind trial of Antipsychotic Treatment of very LAte-onset Schizophrenia-like psychosis: The ATLAS Trial

Trial Profile

A pragmatic randomised double-blind trial of Antipsychotic Treatment of very LAte-onset Schizophrenia-like psychosis: The ATLAS Trial

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Mar 2016

At a glance

  • Drugs Amisulpride (Primary)
  • Indications Schizophrenia and disorders with psychotic features
  • Focus Therapeutic Use
  • Acronyms ATLAS
  • Most Recent Events

    • 29 Feb 2016 Status changed from recruiting to completed, according to ISRCTN: Current Controlled Trials record.
    • 03 Dec 2015 Accrual to date is 87% according to United Kingdom Clinical Research Network record.
    • 04 Nov 2015 Accrual to date is 86% according to United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top